Mortensen ME, Cullen JL
Vuksic T, Zoricic I, Brcic L, Sever M, Klicek R, Radic B, Cesarec V, Berkopic L, Keller N, Blagaic AB, Kokic N, Jelic I, Geber J, Anic T, Seiwerth S, Sikiric P (2007) Stable gastric pentadecapeptide BPC 157 in trials for inflammatory bowel disease (PL-10, PLD-116, PL14736, Pliva, Croatia) heals ileoileal anastomosis in the rat
Users repeatedly acknowledged the high cost but often defended it as justified for cleaner ingredients and better quality control
PMID: 31517177
The disadvantages center on three issues: testicular suppression and infertility, polycythemia risk (the overproduction of red blood cells that raises blood viscosity and thrombotic risk), and the requirement for ongoing exogenous administration with no exit strategy that preserves hormone function
Considerations: MK-677 causes water retention scale weight commonly increases Strong appetite stimulation community sources describe planning nutrition around it Both compounds are widely reported to improve sleep Blood glucose is commonly monitored (MK-677 can affect insulin sensitivity) Community protocols describe: CJC-1295 (no DAC): 100-300mcg before bed MK-677: 10-25mg once daily (evening preferred) Some community sources describe CJC-1295 DAC weekly + daily MK-677 for convenience Common audience: Users seeking broad GH elevation Users who prefer oral dosing for daily use Hard gainers who benefit from appetite increase Users prioritizing sleep-quality improvements Learn more about CJC-1295 | Learn more about MK-677 Ready to buy
.png)
